2.1.1.67	2,3-Dithiopropanol	-	15471	
2.1.1.67	2,4-dithiopyrimidine	-	50477	
2.1.1.67	2,8-dihydroxy-6-mercaptopurine	-	50478	
2.1.1.67	2-amino-6-thiopurine	-	29360	
2.1.1.67	2-Hydroxy-6-mercaptopurine	-	15494	
2.1.1.67	2-mercaptoethanol	-	63	
2.1.1.67	2-methylthio-4-hydroxypyrimidine	1.8 mM, 45% inhibition	50494	
2.1.1.67	2-Methylthiouracil	-	43167	
2.1.1.67	3,4,5-triiodobenzoic acid	-	110163	
2.1.1.67	3,4-dimethoxy-5-hydroxybenzoic acid	-	13314	
2.1.1.67	3,4-dimethoxybenzoic acid	-	9612	
2.1.1.67	3,5-dichlorobenzoic acid	-	110169	
2.1.1.67	3,5-dihydroxy-4-methoxybenzoic acid	-	110170	
2.1.1.67	3,5-dimethylbenzoic acid	-	110171	
2.1.1.67	3,5-dinitrobenzoic acid	-	50505	
2.1.1.67	3-bromo-5-hydroxy-4-methoxybenzoic acid	-	110197	
2.1.1.67	3-chloro-5-hydroxy-4-methoxybenzoic acid	-	110198	
2.1.1.67	3-hydroxy-4,5-dimethoxybenzoic acid	-	110207	
2.1.1.67	3-hydroxy-4-methoxy-5-(dimethylamino)benzoic acid	-	110208	
2.1.1.67	3-hydroxy-4-methoxy-5-nitrobenzoic acid	-	110209	
2.1.1.67	3-hydroxy-4-methoxybenzoic acid	-	50510	
2.1.1.67	3-hydroxy-5-iodo-4-methoxybenzoic acid	-	110211	
2.1.1.67	4-hydroxy-3-methoxybenzoic acid	-	9611	
2.1.1.67	5-amino-salicylic acid	-	109764	
2.1.1.67	5-Aminosalicylate	-	3607	
2.1.1.67	5-methyl-2,4-dithiopyrimidine	-	50558	
2.1.1.67	6-hydroxy-2-thiopurine	-	50565	
2.1.1.67	6-Mercaptopurine	-	1345	
2.1.1.67	6-Mercaptopurine	TPMT activity and protein levels are diminished in cells incubated with 6-mercaptopurine	1345	
2.1.1.67	6-methylmercaptopurine	-	29633	
2.1.1.67	6-methylthiopurine	-	7134	
2.1.1.67	6-thioguanine	mixed inhibitor of 6-mercaptopurine methylation	1253	
2.1.1.67	aspirin	-	3100	
2.1.1.67	Azathioprine	IC50: 0.43-0.532 mM	4790	
2.1.1.67	bendroflumethiazide	-	50643	
2.1.1.67	benzoic acid	substituted benzoic acids, benzoic acid compounds, noncompetitive inhibition	498	
2.1.1.67	benzoic acid	benzoic acid derivatives	498	
2.1.1.67	benzoic acid	-	498	
2.1.1.67	celecoxib	-	1809	
2.1.1.67	diclofenac	-	1291	
2.1.1.67	Disulfiram	-	986	
2.1.1.67	Ethacrynic acid	-	1046	
2.1.1.67	flurbiprofen	-	3816	
2.1.1.67	Furosemide	-	1557	
2.1.1.67	Furosemide	IC50: 0.015-0.019 mM, has the potential to inhibit thiopurine S-methyltransferase in patients with chronic inflammatory bowel disease	1557	
2.1.1.67	glutathione	-	44	
2.1.1.67	Ibuprofen	-	1645	
2.1.1.67	Ketoprofen	-	3079	
2.1.1.67	L-cysteine	1.8 mM, 50% inhibition	74	
2.1.1.67	L-homocysteine	-	305	
2.1.1.67	L-homocysteine thiolactone	-	15818	
2.1.1.67	lornoxicam	-	6300	
2.1.1.67	Mefenamic acid	-	2086	
2.1.1.67	meloxicam	-	5320	
2.1.1.67	mesalazine	-	36968	
2.1.1.67	mesalazine	thiopurine S-methyltransferase inhibition of multimatrix mesalazine is lower than that of time-dependent mesalazine	36968	
2.1.1.67	additional information	low levels of methionine can result in low S-adenosyl-L-methionine levels and consequently decreased TPMT activity	2	
2.1.1.67	N-ethylmaleimide	-	49	
2.1.1.67	nabumetone	-	18650	
2.1.1.67	naproxen	-	1792	
2.1.1.67	olsalazine	-	18662	
2.1.1.67	paracetamol	-	7459	
2.1.1.67	piretanide	IC50: 0.3-0.313 mM	56888	
2.1.1.67	piroxicam	-	4121	
2.1.1.67	S-adenosyl-L-homocysteine	-	36	
2.1.1.67	S-adenosyl-L-methionine	-	24	
2.1.1.67	S-Methylglutathione	-	3363	
2.1.1.67	sulfasalazine	-	4146	
2.1.1.67	sulphasalazine	-	20530	
2.1.1.67	testosterone	IC50: 0.03-0.072 mM	284	
2.1.1.67	tolfenamic acid	-	18661	
2.1.1.67	trichlormethiazide	-	50995	
2.1.1.67	tropolone	-	1033